Bank of Nova Scotia
AMGN icon

Bank of Nova Scotia’s Amgen AMGN Stock Holding History

Bank of Nova Scotia’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$144K – 998
2023
Q4 		$144K Buy
+500
New +$136K ﹤0.01% 973
2016
Q1 		– Sell
-12,900
Closed -$2.09M – 708
2015
Q4 		$2.09M Buy
+12,900
New +$2.03M 0.01% 335

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of Nova Scotia's AMGN Position: Q2 2026 in Review

Bank of Nova Scotia reduced its Amgen (AMGN) stake by 50% in Q2 2026, selling an estimated $54.1M and leaving 156,088 shares worth $56.5M. The position accounts for 0.09% of the portfolio, ranked #179.

Bank of Nova Scotia first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $127M in Q4 2021. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bank of Nova Scotia held 156,088 shares of Amgen worth $56.5M as of Q2 2026.
  • Bank of Nova Scotia sold 158,139 Amgen shares in Q2 2026, an estimated $54.1M.
  • Amgen made up 0.09% of Bank of Nova Scotia's portfolio in Q2 2026, its #179 holding.
  • Bank of Nova Scotia first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Amgen position peaked at $127M in Q4 2021.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.